BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chulkina M, Beswick EJ, Pinchuk IV. Role of PD-L1 in Gut Mucosa Tolerance and Chronic Inflammation. Int J Mol Sci 2020;21:E9165. [PMID: 33271941 DOI: 10.3390/ijms21239165] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Beenen AC, Sauerer T, Schaft N, Dörrie J. Beyond Cancer: Regulation and Function of PD-L1 in Health and Immune-Related Diseases. IJMS 2022;23:8599. [DOI: 10.3390/ijms23158599] [Reference Citation Analysis]
2 Hone Lopez S, Jalving M, Fehrmann RS, Nagengast WB, de Vries EG, de Haan JJ. The gut wall’s potential as a partner for precision oncology in immune checkpoint treatment. Cancer Treatment Reviews 2022;107:102406. [DOI: 10.1016/j.ctrv.2022.102406] [Reference Citation Analysis]
3 Nguyen J, Finkelman BS, Escobar D, Xue Y, Wolniak K, Pezhouh M. Over-expression of Programmed Death Ligand 1 (PD-L1) in Refractory Inflammatory Bowel Disease (IBD). Hum Pathol 2022:S0046-8177(22)00101-0. [PMID: 35489437 DOI: 10.1016/j.humpath.2022.04.011] [Reference Citation Analysis]
4 Yamamoto Y, Carreras J, Shimizu T, Kakizaki M, Kikuti YY, Roncador G, Nakamura N, Kotani A. Anti-HBV drug entecavir ameliorates DSS-induced colitis through PD-L1 induction. Pharmacol Res 2022;:105918. [PMID: 35031477 DOI: 10.1016/j.phrs.2021.105918] [Reference Citation Analysis]
5 Deets KA, Nichols Doyle R, Rauch I, Vance RE. Inflammasome activation leads to cDC1-independent cross-priming of CD8 T cells by epithelial cell-derived antigen. Elife 2021;10:e72082. [PMID: 34939932 DOI: 10.7554/eLife.72082] [Reference Citation Analysis]
6 Matsushima H, Morita-Nakagawa M, Datta S, Pavicic PG Jr, Hamilton TA, Abu-Elmagd K, Fujiki M, Osman M, D'Amico G, Eguchi S, Hashimoto K. Blockade or deficiency of PD-L1 expression in intestinal allograft accelerates graft tissue injury in mice. Am J Transplant 2021. [PMID: 34679256 DOI: 10.1111/ajt.16873] [Reference Citation Analysis]
7 Lee SA, Liu F, Yun DY, Riordan SM, Tay ACY, Liu L, Lee CS, Zhang L. Campylobacter concisus upregulates PD-L1 mRNA expression in IFN-γ sensitized intestinal epithelial cells and induces cell death in esophageal epithelial cells. J Oral Microbiol 2021;13:1978732. [PMID: 34552702 DOI: 10.1080/20002297.2021.1978732] [Reference Citation Analysis]
8 Kang C, Song CH, Kim N, Nam RH, Choi SI, Yu JE, Nho H, Choi JA, Kim JW, Na HY, Lee HN, Surh YJ. The Enhanced Inhibitory Effect of Estrogen on PD-L1 Expression Following Nrf2 Deficiency in the AOM/DSS Model of Colitis-Associated Cancer. Front Oncol 2021;11:679324. [PMID: 34307147 DOI: 10.3389/fonc.2021.679324] [Reference Citation Analysis]
9 Ponce de León C, Lorite P, López-Casado MÁ, Barro F, Palomeque T, Torres MI. Significance of PD1 Alternative Splicing in Celiac Disease as a Novel Source for Diagnostic and Therapeutic Target. Front Immunol 2021;12:678400. [PMID: 34220824 DOI: 10.3389/fimmu.2021.678400] [Reference Citation Analysis]